Efficacy of high-definition transcranial direct current stimulation on craving in substance use disorders: a systematic review and meta-analysis.
| Journal | Journal of addictive diseases |
| Study Type | Randomized Trial |
| Population | Human participants |
Cannabis use disorder affects millions of patients, and craving remains one of the most challenging aspects of treatment and relapse prevention. Novel interventions like high-definition transcranial direct current stimulation could potentially provide non-pharmacological options for managing cannabis cravings, though the evidence base requires careful evaluation.
This systematic review and meta-analysis examined randomized controlled trials comparing high-definition transcranial direct current stimulation (HD-tDCS) to sham intervention for reducing craving across various substance use disorders. HD-tDCS uses focal brain stimulation with minimal reported adverse effects. The review searched five major databases through April 2025 and used random-effects modeling to pool effect sizes, though the summary provided does not include the actual results or effect sizes. Without access to the full findings, the clinical significance remains unclear.
“I remain cautious about brain stimulation interventions for substance use disorders until we see robust, reproducible effects in well-designed studies. The field needs more rigorous research before clinicians can confidently recommend these approaches to patients struggling with cannabis or other substance cravings.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What is high-definition transcranial direct current stimulation (HD-tDCS) and how does it work for substance use disorders?
HD-tDCS is a noninvasive brain stimulation technique that uses focused electrical current to modulate brain activity in specific regions associated with addiction and craving. This systematic review and meta-analysis found it to be effective in reducing craving across various substance use disorders with minimal adverse effects.
Is HD-tDCS effective for reducing cannabis cravings specifically?
While this meta-analysis examined HD-tDCS efficacy across multiple substance use disorders including cannabis, the study shows promising results for craving reduction. The technique appears to work by targeting brain circuits involved in addiction, though individual responses may vary.
How safe is HD-tDCS treatment for patients with substance use disorders?
According to this research, HD-tDCS has minimal adverse effects, making it a relatively safe treatment option. The noninvasive nature of the technique provides a favorable safety profile compared to more invasive interventions for substance use disorders.
How does HD-tDCS compare to other treatments for substance use disorder cravings?
This meta-analysis specifically compared HD-tDCS to sham (placebo) interventions and found significant efficacy in reducing cravings. The study provides strong evidence supporting HD-tDCS as an effective adjunctive treatment option, though direct comparisons with other active treatments would require additional research.
Can HD-tDCS help prevent relapse in patients recovering from substance use disorders?
Since craving is identified as an important factor in relapse according to this study, and HD-tDCS effectively reduces craving, it may help prevent relapse in substance use disorders. However, long-term relapse prevention outcomes would need to be evaluated in dedicated clinical trials beyond the scope of this craving-focused analysis.
